uPA Receptor, Human, ELISA Kit, Quantikine (96well)

データシート※最新のデータシートでない場合があります

• 商品コード：DUP00
• メーカー：RSD
• 包装：1kit
• 価格： ¥116,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Kroon ME et al. Hypoxia in combination with FGF-2 induces tube formation by human microvascular endothelial cells in a fibrin matrix: involvement of at least two signal transduction pathways. J. Cell. Sci. 2001 Feb;114(Pt 4):825-33
  Kroon ME et al
  2001/01/01
  
• 備考：
  HUVEC culture supernate
• 参照：
  

• No.： 2
• 文献情報：
  George ML et al. VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia ;3(5):420-7
  George ML et al
  
• 備考：
  human serum
• 参照：
  

• No.： 3
• 文献情報：
  Jumper C et al. The circulating urokinase plasminogen activator (uPA) and its soluble receptor (suPAR) are not up-regulated by the circulating P105 fraction of the HER-2/neu proto-oncogene: in vivo evidence from patients with advanced non-small cell lung
  Jumper C et al
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 4
• 文献情報：
  Rigolin GM et al. Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patients. Br. J. Haematol. 2003 Mar;120(6):953-9
  Rigolin GM et al
  2003/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 5
• 文献情報：
  Cobos E et al. Pretreatment determination of the serum urokinase plasminogen activator and its soluble receptor in advanced small-cell lung cancer or non-small-cell lung cancer. Clin. Appl. Thromb. Hemost. 2003 Jul;9(3):241-6
  Cobos E et al
  2003/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 6
• 文献情報：
  Wang J et al. The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression. Clin. Cancer Res. 2004 Sep;10(18 Pt 1):6169-78
  Wang J et al
  2004/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 7
• 文献情報：
  Lash GE et al. Low oxygen concentrations inhibit trophoblast cell invasion from early gestation placental explants via alterations in levels of the urokinase plasminogen activator system. Biol. Reprod. 2006 Feb;74(2):403-9
  Lash GE et al
  2006/01/01
  
• 備考：
  placental explant
• 参照：
  

• No.： 8
• 文献情報：
  Brooks AM et al. Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma. Am. J. Respir. Cell Mol. Biol. 2006 Oct;35(4):503-11
  Brooks AM et al
  2006/01/01
  
• 備考：
  Species: Human, Sample type: BALF
• 参照：
  

• No.： 9
• 文献情報：
  Beaufort N et al. The human airway trypsin-like protease modulates the urokinase receptor (uPAR, CD87) structure and functions. Am. J. Physiol. Lung Cell Mol. Physiol. 2007 May;292(5):L1263-72
  Beaufort N et al
  2007/01/01
  
• 備考：
  Species: Human, Sample type: Cell Supernates
• 参照：
  

• No.： 10
• 文献情報：
  Zuckerman ST et al. Identification of regulatory Hck and PAI-2 proteins in the monocyte response to PEG-containing matrices. Biomaterials 2009 Aug;30(23-24):3825-33
  Zuckerman ST et al
  2009/01/01
  
• 備考：
  Sample Type: Cell Supernates
• 参照：
  

• No.： 11
• 文献情報：
  Wei C et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat. Med. 2011 Aug;17(8):952-60
  Wei C et al
  2011/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 12
• 文献情報：
  Maas RJ et al. Serum-soluble urokinase receptor concentration in primary FSGS. Kidney Int. 2012 May;81(10):1043-4
  Maas RJ et al
  2012/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 13
• 文献情報：
  Meijers B et al. The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis. Kidney Int. 2014 Mar;85(3):636-40
  Meijers B et al
  2014/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 14
• 文献情報：
  Sinha A et al. Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children. Kidney Int. 2014 Mar;85(3):649-58
  Sinha A et al
  2014/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 15
• 文献情報：
  Huang J et al. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis. BMC Med 2014;12:81
  Huang J et al
  2014/01/01
  
• 備考：
  Sample Type: Urine
• 参照：
  

• No.： 16
• 文献情報：
  Meijers B et al. Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease. Kidney Int. 2015 Jan;87(1):210-6
  Meijers B et al
  2015/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 17
• 文献情報：
  Spinale JM et al. A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease. Kidney Int. 2015 Mar;87(3):564-74
  Spinale JM et al
  2015/01/01
  
• 備考：
  Sample Type: Blood,Urine
• 参照：
  

• No.： 18
• 文献情報：
  Chang MC et al. p-Cresol affects reactive oxygen species generation, cell cycle arrest, cytotoxicity and inflammation/atherosclerosis-related modulators production in endothelial cells and mononuclear cells. PLoS ONE 2014;9(12):e114446
  Chang MC et al
  2014/01/01
  
• 備考：
  Sample Type: whole cells
• 参照：
  

• No.： 19
• 文献情報：
  Gilder AS et al. Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion. J. Biol. Chem. 2015 Jun;290(24):14798-809
  Gilder AS et al
  2015/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 20
• 文献情報：
  Lane D et al. Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers. BMC Cancer 2015;15:492
  Lane D et al
  2015/01/01
  
• 備考：
  Sample Type: BALF
• 参照：
  

• No.： 21
• 文献情報：
  Zhao Y et al. Plasma Soluble Urokinase Receptor Level Is Correlated with Podocytes Damage in Patients with IgA Nephropathy. PLoS ONE 2015;10(7):e0132869
  Zhao Y et al
  2015/01/01
  
• 備考：
  Sample Type: Plasma
• 参照：
  

• No.： 22
• 文献情報：
  Guo SM et al. Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China. PLoS ONE 2015;10(9):e0138718
  Guo SM et al
  2015/01/01
  
• 備考：
  Sample Type: Plasma
• 参照：
  

• No.： 23
• 文献情報：
  Guthoff M et al. Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus. Sci Rep 2017 Jan;7:40627
  Guthoff M et al
  2017/01/01
  
• 備考：
  Sample Type: Serum
• 参照：
  

• No.： 24
• 文献情報：
  Wu W et al. Soluble Urokinase Plasminogen Activator Receptor is Associated with Coronary Artery Calcification and Cardiovascular Disease in Patients Undergoing Hemodialysis. Kidney Blood Press. Res. 2018;43(3):664-672
  Wu W et al
  2018/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 25
• 文献情報：
  Hayek SS et al. Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein. J Am Heart Assoc 2018 May;7(9)
  Hayek SS et al
  2018/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 26
• 文献情報：
  Koh AS et al. Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation. BMC Geriatr 2017 Nov;17(1):275
  Koh AS et al
  2017/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 27
• 文献情報：
  Kikuchi K et al. Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease. Nat Commun 2019 04;10(1):1835
  Kikuchi K et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 28
• 文献情報：
  Beckert L et al. Phase 1 trial of intrapleural LTI-01; single chain urokinase in complicated parapneumonic effusions or empyema. JCI Insight 2019 Apr;5
  Beckert L et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 29
• 文献情報：
  Kolber W et al. Serum Urokinase-Type Plasminogen Activator Receptor Does Not Outperform C-Reactive Protein and Procalcitonin as an Early Marker of Severity of Acute Pancreatitis. J Clin Med 2018 Sep;7(10)
  Kolber W et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 30
• 文献情報：
  Shuster S et al. Fetal Renal Echogenicity Associated with Maternal Focal Segmental Glomerulosclerosis: The Effect of Transplacental Transmission of Permeability Factor suPAR. J Clin Med 2018 Oct;7(10)
  Shuster S et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 31
• 文献情報：
  Torino C et al. Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients. Kidney Int Rep 2018 Sep;3(5):1100-1109
  Torino C et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 32
• 文献情報：
  Zhou J et al. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway. Cell. Physiol. Biochem. 2018;47(5):1909-1924
  Zhou J et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 33
• 文献情報：
  Luo Q et al. Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study. Crit Care 2018 01;22(1):15
  Luo Q et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 34
• 文献情報：
  Winnicki W et al. Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method. Sci Rep 2019 09;9(1):13783
  Winnicki W et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 35
• 文献情報：
  An JN et al. Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis. Sci Rep 2019 10;9(1):14707
  An JN et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 36
• 文献情報：
  Wajda J et al. The Marker of Tubular Injury, Kidney Injury Molecule-1 (KIM-1), in Acute Kidney Injury Complicating Acute Pancreatitis: A Preliminary Study. J Clin Med 2020 May;9(5)
  Wajda J et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 37
• 文献情報：
  Li X et al. Salvianolic acid A attenuates steroid resistant nephrotic syndrome through suPAR/uPAR-αvβ3 signaling Inhibition. J Ethnopharmacol 2021 Oct;279:114351
  Li X et al
  2021/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 38
• 文献情報：
  Jehn U et al. Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients. Sci Rep 2021 Feb;11(1):3713
  Jehn U et al
  2021/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 39
• 文献情報：
  Huang F et al. The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis. Mediators Inflamm 2020;2020:7850179
  Huang F et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：